{"id":"NCT03337724","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer","officialTitle":"A Double-Blind, Placebo-Controlled, Randomized Phase III Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Patients With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-01-06","primaryCompletion":"2023-01-04","completion":"2023-01-04","firstPosted":"2017-11-09","resultsPosted":"2024-03-12","lastUpdate":"2024-03-12"},"enrollment":579,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"DRUG","name":"Ipatasertib","otherNames":[]},{"type":"DRUG","name":"Paclitaxel","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ipatasertib + Paclitaxel","type":"EXPERIMENTAL"},{"label":"Placebo + Paclitaxel","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the efficacy of ipatasertib + paclitaxel versus placebo + paclitaxel in participants with histologically confirmed, locally advanced or metastatic triple-negative breast cancer (TNBC) and in participants with locally advanced or metastatic hormone receptor positive (HR+)/ human epidermal growth factor receptor 2 negative (HER2-) breast adenocarcinoma who are not suitable for endocrine therapy.","primaryOutcome":{"measure":"Cohort A: Progression-Free Survival (PFS)","timeFrame":"From randomization up to 27 months","effectByArm":[{"arm":"Cohort A: Placebo + Paclitaxel","deltaMin":6.1,"sd":null},{"arm":"Cohort A: Ipatasertib + Paclitaxel","deltaMin":7.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.9237"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":21},"locations":{"siteCount":176,"countries":["United States","Argentina","Australia","Belgium","Brazil","Canada","Chile","Costa Rica","Czechia","France","Germany","Greece","Hungary","India","Italy","Japan","Mexico","North Macedonia","Peru","Poland","Russia","Singapore","Slovenia","South Africa","South Korea","Spain","Taiwan","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["34860318"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":87},"commonTop":["Diarrhoea","Alopecia","Nausea","Constipation","Anaemia"]}}